[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2639 followers Created: 2025-07-24 20:02:22 UTC $RVMD Revolution Medicines announces publication in Science on Zoldonrasib, a selective inhibitor for RAS(ON) G12D. Discovery and development detailed in peer-reviewed paper. More Info: $XBI $IBB $XPH $PPH  XXX engagements  **Related Topics** [$pph](/topic/$pph) [$xph](/topic/$xph) [$ibb](/topic/$ibb) [$xbi](/topic/$xbi) [more info](/topic/more-info) [$rvmd](/topic/$rvmd) [Post Link](https://x.com/OzmosiHealth/status/1948473855816659447)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Ozmosi @OzmosiHealth on x 2639 followers
Created: 2025-07-24 20:02:22 UTC
$RVMD Revolution Medicines announces publication in Science on Zoldonrasib, a selective inhibitor for RAS(ON) G12D. Discovery and development detailed in peer-reviewed paper.
More Info: $XBI $IBB $XPH $PPH
XXX engagements
/post/tweet::1948473855816659447